Related Experiment Video
Updated: Sep 24, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.5K
Alcohol abstinence reduces A-fib burden in drinkers
Derrick J Thiel1, Robert C Marshall1, Tyler S Rogers1
1Madigan Army Medical Center, Joint Base Lewis-McChord, WA.
The Journal of Family Practice
|May 4, 2022
Summary
Regular drinkers who stopped drinking alcohol experienced less atrial fibrillation (A-fib) recurrence and burden. This Australian study highlights alcohol abstinence as a key factor in managing A-fib.
Area of Science:
- Cardiology
- Public Health
Background:
- Atrial fibrillation (A-fib) is a common heart arrhythmia.
- Alcohol consumption is a known risk factor for cardiovascular diseases, including A-fib.
Purpose of the Study:
- To investigate the impact of alcohol abstinence on atrial fibrillation (A-fib) recurrence and burden.
- To assess the role of regular drinkers in A-fib management.
Main Methods:
- A study was conducted in Australia.
- Participants included regular alcohol drinkers with a history of A-fib.
- The study compared A-fib recurrence and burden between periods of alcohol consumption and abstinence.
Main Results:
- A significant reduction in A-fib recurrence was observed among participants who abstained from alcohol.
- A notable decrease in A-fib burden was also demonstrated during periods of alcohol abstinence.
- The findings were significant for regular drinkers.
Conclusions:
- Alcohol abstinence can lead to a significant reduction in atrial fibrillation (A-fib) recurrence and burden.
- Reducing or eliminating alcohol intake may be a beneficial strategy for managing A-fib in regular drinkers.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
50
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
50
01:26Coronary Artery Disease IV: Preventive Measures
47
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
47
01:27CNS Depressants: Alcohol and Nicotine
378
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
378
02:23Alcohols from Carbonyl Compounds: Reduction
10.9K
Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
10.9K
01:25Dysrhythmias VI: Management of Dysrhythmias
123
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
123
01:20Exercise and Cardiovascular Response
1.1K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K